Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The prognostic and predictive value of peripheral immune-related proteins in patients with lung cancer treated with radiotherapy. | Front Oncol | 2025 | 40746594 | PubTator, text mining | PubMed |
| HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production. | iScience | 2025 | 40678535 | PubTator, text mining | PubMed |
| Quantitative phase imaging with temporal kinetics predicts hematopoietic stem cell diversity. | Nat Commun | 2025 | 40659629 | PubTator, text mining | PubMed |
| VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children. | Sci Rep | 2025 | 40610562 | PubTator, text mining | PubMed |
| Single-cell transcriptomics analysis reveals a disrupted NK-T cell interaction network in liver metastatic cancer. | Sci Rep | 2025 | 40594834 | PubTator, text mining | PubMed |
| CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms. | Cancer Genomics Proteomics | 2025 | 40571312 | PubTator, text mining | PubMed |
| Identifying the potential therapeutic targets of tertiary lymphoid structure in IgA nephropathy based on bioinformatics. | Autoimmunity | 2025 | 40549784 | PubTator, text mining | PubMed |
| Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3. | Pathol Oncol Res | 2025 | 40510503 | PubTator, text mining | PubMed |
| SGSM1 as a pan-cancer biomarker: multi-omics insights into immune regulation, prognostic value, and therapeutic implications. | Discov Oncol | 2025 | 40500484 | PubTator, text mining | PubMed |
| Decoding the maternal-fetal dialogue: NK cell education in reproductive outcomes†. | Biol Reprod | 2025 | 40476707 | PubTator, text mining | PubMed |
| Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | 40386726 | PubTator, text mining | PubMed |
| Human naïve B cells show evidence of anergy and clonal redemption following vaccination. | NPJ Vaccines | 2025 | 40368926 | PubTator, text mining | PubMed |
| Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma. | Cancer Sci | 2025 | 40355804 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker. | Front Immunol | 2025 | 40276502 | PubTator, text mining | PubMed |
| DNA methylation-predicted plasma protein levels and breast cancer risk. | Breast Cancer Res | 2025 | 40140843 | PubTator, text mining | PubMed |
| Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia. | Mol Ther | 2025 | 40087865 | PubTator, text mining | PubMed |
| Analysis of Antigen Expression in T-Cell Acute Lymphoblastic Leukemia by Multicolor Flow Cytometry: Implications for the Detection of Measurable Residual Disease. | Int J Mol Sci | 2025 | 40076625 | PubTator, text mining | PubMed |
| The thylakoid protein BCM1 sequesters antennae protein CP24 and CP29 within the grana cores thereby reducing their exposure to degradation under heat stress. | Plant J | 2025 | 40026239 | PubTator, text mining | PubMed |
| Functional study of tilapia T cell activation stimulus signal molecule CD2. | Fish Shellfish Immunol | 2025 | 39909121 | PubTator, text mining | PubMed |
| Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells. | iScience | 2025 | 39886466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=5